+65 3158 9910
1300 798 820
+64 9801 0299
P1=Phase I; P2=Phase II; P3=Phase III; RF=Regulatory Filing & Approval
Breast: Metastatic
Breast: Metastatic (triple negative, 1st-line) + carboplatin
Breast: Metastatic (triple negative, 1st-line) + atezolizumab
Breast: Early (neoadjuvant)
Breast: Early (triple negative, 1st-line) + carboplatin + atezolizumab
Breast: Early (triple negative) + pembrolizumab
Pancreatic: Metastatic (1st-line) + gemcitabine
Pancreatic: Adjuvant + gemcitabine
Lung: Advanced NSCLC (1st-line) + carboplatin
Lung: Adv Non-squamous NSCLC (1st-line)+ carboplatin + atezolizumab
Melanoma: Metastatic
HER2+ Early Breast Cancer (extended adjuvant)
HER2+ Metastatic Breast Cancer (3rd line)
Metastatic Breast Cancer (HER2 non-amplified, HER2 mutant)
HER2+ Metastatic Breast Cancer (combination with T-DM1)
Metastatic Breast Cancer with Brain Metastases
Early Breast Cancer (neoadjuvant) I-SPY 2
Solid Tumours with EGFR mutations (basket trial)
Small Cell Lung Cancer (SCLC)
BRCA 1/2 Breast Cancer
Cancer – Basket Trial
Mesothelioma
Mesothelioma (SEALIGHT)
Relapsed SCLC (LAGOON)
Leiomyosarcoma and Liposarcoma
Refractory/Relapsed GIST (INVICTUS)
GIST (2nd Line) (INTRIGUE)
Breast Cancer Assay (Node -) (TAILORx)
Breast Cancer Assay (Node +) (RxPONDER)
DCIS Assay (DUCHESS)
Colon Cancer Assay
Cholangiocarcinoma (previously treated) FIGHT-202
Cholangiocarcinoma (previously untreated) FIGHT-302
Nasopharyngeal Carcinoma
P1=Phase I; P2=Phase II; P3=Phase III; RF=Regulatory Filling & Approval
COVID-19 Treatments
Refractory / relapsed multiple myeloma
KRAS+ Non-Small Cell Lung Cancer (NSCLC, Oral)
High-Risk Myelodysplastic Syndrome (MDS) (2nd line IV)
Relapsed/refractory diffuse large B-cell lymphoma (DLBCL)
Newly Diagnosed diffuse large B-cell lymphoma (DLBCL)
Cancer anorexia-cachexia in NSCLC patients
Diabetic macular oedema
Visualisation during surgery for malignant glioma
To learn more about the clinical trials that are underway and to find out if a study is enrolling patients in your area, please visit www.clinicaltrials.gov